DXCM vs TMP · P/E 63, rev $4.03B vs P/E 7.5, rev $79.3M
DexCom Inc (DXCM) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the DXCM and TMP stock pages for the full models.
Not investment advice.